Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Frontiers in Microbiology
|
April 9, 2021
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples
Lia Oliver, Sara Ramió-Pujol, Joan Amoedo, et al.
Medicine
|
November 16, 2018
Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosis
Carmen Monsalve-Hernando, Laura Crespo, Blanca Ferreiro, et al.
United European Gastroenterology Journal
|
February 14, 2018
Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia
Luis Bujanda, Cristina Sarasqueta, Pablo Vega, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment
David Busquets, Lia Oliver, Joan Amoedo, et al.
BMC Medicine
|
September 2, 2016
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
Joaquín Cubiella, Pablo Vega, María Salve, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2019
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
Plos One
|
February 16, 2024
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study
Aleix Lluansí, Marc Llirós, Robert Carreras-Torres, et al.
Pharmaceutics
|
May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, et al.
Therapeutic Advances in Gastroenterology
|
March 6, 2024
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU
Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Frontiers in Microbiology
|
April 9, 2021
A Novel Grape-Derived Prebiotic Selectively Enhances Abundance and Metabolic Activity of Butyrate-Producing Bacteria in Faecal Samples
Lia Oliver, Sara Ramió-Pujol, Joan Amoedo, et al.
Medicine
|
November 16, 2018
Phase IV noninferiority controlled randomized trial to evaluate the impact on diagnostic thinking and patient management and the test-retest reproducibility of the Gaxilose test for hypolactasia diagnosis
Carmen Monsalve-Hernando, Laura Crespo, Blanca Ferreiro, et al.
United European Gastroenterology Journal
|
February 14, 2018
Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia
Luis Bujanda, Cristina Sarasqueta, Pablo Vega, et al.
Inflammatory Bowel Diseases
|
November 18, 2021
RAID Prediction: Pilot Study of Fecal Microbial Signature With Capacity to Predict Response to Anti-TNF Treatment
David Busquets, Lia Oliver, Joan Amoedo, et al.
BMC Medicine
|
September 2, 2016
Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
Joaquín Cubiella, Pablo Vega, María Salve, et al.
Alimentary Pharmacology & Therapeutics
|
April 27, 2019
Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers
Marta Malagón, Sara Ramió-Pujol, Marta Serrano, et al.
Plos One
|
February 16, 2024
Impact of bread diet on intestinal dysbiosis and irritable bowel syndrome symptoms in quiescent ulcerative colitis: A pilot study
Aleix Lluansí, Marc Llirós, Robert Carreras-Torres, et al.
Pharmaceutics
|
May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA
Celia Gómez-Labrador, Elena Ricart, Marisa Iborra, et al.
Therapeutic Advances in Gastroenterology
|
March 6, 2024
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Therapeutic Advances in Gastroenterology
|
February 24, 2026
Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU
Francisco Mesonero, Yamile Zabana, Agnès Fernández-Clotet, et al.
Page
of 2